Alps Advisors Inc Gossamer Bio, Inc. Transaction History

Alps Advisors Inc

$17.2 Billion
Q2 2025

A detailed history of Alps Advisors Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 122,644 shares of GOSS stock, worth $278,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares

122,644

Holding current value

$278,401

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$0.78 - $1.44 $95,662 - $176,607	122,644 New	122,644 $150,000
Q2 2022 Aug 11, 2022	SELL	$5.97 - $9.97 $469,259 - $783,671	-78,603 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $83,420 - $123,451	-9,884 Reduced 11.17%	78,603 $682,000
Q4 2021 Feb 09, 2022	SELL	$10.12 - $14.07 $47,047 - $65,411	-4,649 Reduced 4.99%	88,487 $1 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $49,626 - $90,559	-6,845 Reduced 6.85%	93,136 $1.17 Million
Q2 2021 Aug 11, 2021	SELL	$8.0 - $9.75 $299,120 - $364,552	-37,390 Reduced 27.22%	99,981 $812,000
Q1 2021 May 07, 2021	BUY	$8.63 - $10.94 $2,675 - $3,391	310 Added 0.23%	137,371 $1.27 Million
Q4 2020 Feb 03, 2021	BUY	$8.3 - $13.59 $334,963 - $548,451	40,357 Added 41.73%	137,061 $1.33 Million
Q3 2020 Nov 04, 2020	SELL	$11.3 - $14.75 $75,190 - $98,146	-6,654 Reduced 6.44%	96,704 $1.2 Million
Q2 2020 Aug 05, 2020	SELL	$9.52 - $15.98 $158,993 - $266,881	-16,701 Reduced 13.91%	103,358 $1.34 Million
Q1 2020 May 06, 2020	SELL	$8.0 - $15.48 $104,000 - $201,240	-13,000 Reduced 9.77%	120,059 $1.22 Million
Q4 2019 Feb 07, 2020	BUY	$14.82 - $26.79 $24,275 - $43,882	1,638 Added 1.25%	133,059 $2.08 Million
Q3 2019 Nov 04, 2019	SELL	$16.02 - $22.47 $104,194 - $146,144	-6,504 Reduced 4.72%	131,421 $2.21 Million
Q2 2019 Aug 07, 2019	BUY	$16.12 - $22.89 $2.22 Million - $3.16 Million	137,925 New	137,925 $3.06 Million

Others Institutions Holding GOSS

# of Institutions

145

Shares Held

159M

Call Options Held

2.89M

Put Options Held

130K

Octagon Capital Advisors LP New York, NY

18.4M
Shares

$41.7 Million
8.57% of portfolio
Nea Management Company, LLC Timonium, MD

18.1M
Shares

$41.1 Million
1.84% of portfolio
Vanguard Group Inc Valley Forge, PA

11.4M
Shares

$25.9 Million
0.0% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$18.3 Million
5.25% of portfolio
Acadian Asset Management LLC Boston, MA

7.15M
Shares

$16.2 Million
0.02% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $213M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account